Strahlentherapie und Onkologie

, Volume 175, Issue 6, pp 295–296

Effektivität der bilateralen mastektomie bei frauen mit familiärer brustkrebsanamnese

  • Bernd Gerber
  • Klaus Friese
Literatur kommentiert
  • 15 Downloads

Literatur

  1. 1.
    Couch FJ, DeShano MI., Blackwood MA. et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer [see comments]. N Engl J Med 1997;336:1409–15.CrossRefPubMedGoogle Scholar
  2. 2.
    Fisher B, Costantino JP, Wickerham DL. et al. Tamoxifen for prevention of breast cancel: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study..1 Natl Cancer Inst 1998;90: 1371–88.CrossRefGoogle Scholar
  3. 3.
    Ford D, Hasten DF. Bishop DT. et al. Risks of cancer in BRCA.Imutation carriers. Breast Cancer Linkage Consortium. Lancet 1994;543:692–5.CrossRefGoogle Scholar
  4. 4.
    Hartmann LC. Schaid DJ. Woods JF, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer [see comments]. N Engl J Med 1999;340:77–84.CrossRefPubMedGoogle Scholar
  5. 5.
    Vasen HF, Haites NE, Evans DG, et al. Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group. Eur J Cancer 1998:34:1022–6.CrossRefGoogle Scholar
  6. 6.
    Verhoog LC, Brekelmans CT, Seynaeve C. ct al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRC A1 [see comments]. Lancet 1998:351:316–21.CrossRefPubMedGoogle Scholar

Copyright information

© Urban & Vogel 1999

Authors and Affiliations

  • Bernd Gerber
    • 1
  • Klaus Friese
    • 1
  1. 1.Roslock

Personalised recommendations